Results 11 to 20 of about 9,756 (290)
Adult Case of Congenital Intratympanic Membrane Cholesteatoma. [PDF]
Clin Case RepABSTRACT Intratympanic membrane cholesteatoma (ITMC) is a rare type of cholesteatoma located within the tympanic membrane. Surgery is a treatment option if the ITMCs do not spontaneously disappear. Transcanal endoscopic ear surgery is anticipated to become the standard approach in the future.
Fukui J +7 more
europepmc +4 more sources
Intratympanic gentamicin for Ménière’s disease
Cochrane Database of Systematic Reviews, 2023 Background Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Aminoglycosides are sometimes administered directly into the middle ear to treat this condition.
K. Webster +10 more
semanticscholar +6 more sources
Intratympanic corticosteroids for Ménière’s disease
Cochrane Database of Systematic Reviews, 2021 Background Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Corticosteroids are sometimes administered directly into the middle ear to treat this condition (through the tympanic ...
K. Webster +11 more
semanticscholar +7 more sources
Intratympanic treatment for tinnitus: A review
Noise and Health, 2013 Since the 1940s, various attempts have been made to treat peripheral tinnitus by way of intratympanic injection. This administration procedure requires only low concentrations of medication, thanks to the highly targeted delivery to the site of action ...
Thomas Meyer
doaj +3 more sources
Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss [PDF]
Iranian Journal of Otorhinolaryngology, 2021 Introduction: Oral prednisolone was suggested as the first step to treat idiopathic sudden sensorineural hearing loss (ISSHL). This study aimed to investigate the effect of pulse therapy with methylprednisolone and intratympanic methylprednisolone ...
Maryam Amizadeh +3 more
doaj +1 more source
Intratympanic Steroid for the Management of Sudden Hearing Loss: Introduction of a Tapering Method [PDF]
Iranian Journal of Otorhinolaryngology, 2022 Introduction:Sudden sensorineural hearing loss (SSNHL) is a therapeutic challenge. There are several controversies regarding the management protocol of SSNHL.
Mohsen Rajati +5 more
doaj +1 more source
Efficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus. [PDF]
LaryngoscopeIntratympanic Botulinum toxin (IT‐BTX) injection appears to be an effective and safe treatment for MEMT, significantly reducing tinnitus‐related symptoms without complications. In a retrospective study of 57 patients, THI scores and VAS measures for loudness, awareness, annoyance, and life impact improved significantly over 6 months.
Lim JH +8 more
europepmc +2 more sources
Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone
Journal of Korean medical science, 2023 Background In this study, we prepared and evaluated an injectable poloxamer (P407) hydrogel formulation for intratympanic (IT) delivery of dexamethasone (DEX).
Thi Phuc Le +7 more
semanticscholar +1 more source
Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss. [PDF]
, 2021 Objectives/hypothesisTo examine the hearing outcomes of patients with sudden sensorineural hearing loss (SSNHL) treated with oral and intratympanic (IT) steroid only or a combination of steroid and migraine treatment.
Abouzari, Mehdi +7 more
core +1 more source